Get SET Early to Identify and Treatment Refer Autism Spectrum Disorder at 1 Year and Discover Factors That Influence Early Diagnosis.


Journal

The Journal of pediatrics
ISSN: 1097-6833
Titre abrégé: J Pediatr
Pays: United States
ID NLM: 0375410

Informations de publication

Date de publication:
Sep 2021
Historique:
received: 23 12 2020
revised: 20 04 2021
accepted: 21 04 2021
pubmed: 30 4 2021
medline: 27 11 2021
entrez: 29 4 2021
Statut: ppublish

Résumé

To examine the impact of a new approach, Get SET Early, on the rates of early autism spectrum disorder (ASD) detection and factors that influence the screen-evaluate-treat chain. After attending Get SET Early training, 203 pediatricians administered 57 603 total screens using the Communication and Symbolic Behavior Scales Infant-Toddler Checklist at 12-, 18-, and 24-month well-baby examinations, and parents designated presence or absence of concern. For screen-positive toddlers, pediatricians specified if the child was being referred for evaluation, and if not, why not. Collapsed across ages, toddlers were evaluated and referred for treatment at a median age of 19 months, and those screened at 12 months (59.4% of sample) by 15 months. Pediatricians referred one-third of screen-positive toddlers for evaluation, citing lack of confidence in the accuracy of screen-positive results as the primary reason for nonreferral. If a parent expressed concerns, referral probability doubled, and the rate of an ASD diagnosis increased by 37%. Of 897 toddlers evaluated, almost one-half were diagnosed as ASD, translating into an ASD prevalence of 1%. The Get SET Early model was effective at detecting ASD and initiating very early treatment. Results also underscored the need for change in early identification approaches to formally operationalize and incorporate pediatrician judgment and level of parent concern into the process.

Identifiants

pubmed: 33915154
pii: S0022-3476(21)00392-9
doi: 10.1016/j.jpeds.2021.04.041
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

179-188

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH110558
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH104446
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH080134
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH118879
Pays : United States
Organisme : NIDCD NIH HHS
ID : R01 DC016385
Pays : United States

Informations de copyright

Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.

Auteurs

Karen Pierce (K)

Department of Neurosciences, University of California, San Diego, La Jolla, CA. Electronic address: kpierce@health.ucsd.edu.

Vahid Gazestani (V)

Department of Neurosciences, University of California, San Diego, La Jolla, CA; Department of Pediatrics, University of California, San Diego, La Jolla, CA.

Elizabeth Bacon (E)

Department of Neurosciences, University of California, San Diego, La Jolla, CA.

Eric Courchesne (E)

Department of Neurosciences, University of California, San Diego, La Jolla, CA.

Amanda Cheng (A)

Department of Neurosciences, University of California, San Diego, La Jolla, CA.

Cynthia Carter Barnes (CC)

Department of Neurosciences, University of California, San Diego, La Jolla, CA.

Srinivasa Nalabolu (S)

Department of Neurosciences, University of California, San Diego, La Jolla, CA.

Debra Cha (D)

Department of Neurosciences, University of California, San Diego, La Jolla, CA.

Steven Arias (S)

Department of Neurosciences, University of California, San Diego, La Jolla, CA.

Linda Lopez (L)

Department of Neurosciences, University of California, San Diego, La Jolla, CA.

Christie Pham (C)

Department of Neurosciences, University of California, San Diego, La Jolla, CA.

Kim Gaines (K)

San Diego Regional Center, San Diego, CA.

Gohar Gyurjyan (G)

San Diego Regional Center, San Diego, CA.

Terri Cook-Clark (T)

San Diego Regional Center, San Diego, CA.

Kathy Karins (K)

San Diego Regional Center, San Diego, CA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH